Trials / Unknown
UnknownNCT05861869
Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 450 (estimated)
- Sponsor
- Zhejiang Biostar Biotechnology Co. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this observational clinical trial is to compare assessment reagents with clinical diagnostic criteria in patients with membranous nephropathy. The main questions it aims to answer are: * Evaluating the sensitivity and specificity of the test reagent in the diagnosis of membranous nephropathy. * Evaluating whether the clinical diagnostic performance of the test reagent meets the requirements for auxiliary diagnosis of membranous nephropathy. Participants will provide approximately 4ml of blood. Researchers will compare the levels of anti-PLA2RIgG4 in patients with membranous nephropathy and patients with other renal diseases,to see if there is a significant difference.
Conditions
Timeline
- Start date
- 2023-05-04
- Primary completion
- 2024-02-01
- Completion
- 2024-06-01
- First posted
- 2023-05-17
- Last updated
- 2024-02-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05861869. Inclusion in this directory is not an endorsement.